Gilead

Gilead News

COVID-19 crisis: Gilead announces steps to expand availability of Remdesivir in India
India

COVID-19 crisis: Gilead announces steps to expand availability of Remdesivir in India

The pharma co is set to provide support for new manufacturing facilities, and will donate active pharmaceutical ingredients to increase production

Oprah Winfrey chooses Pulitzer-winner Marilynne Robinson's 'Gilead' novel series for her book club
Arts & Culture

Oprah Winfrey chooses Pulitzer-winner Marilynne Robinson's 'Gilead' novel series for her book club

Marilynne Robinson won the Pulitzer Prize in 2005 for Gilead, the first of her books set in the fictional Iowa town of Gilead, and she has followed with Home, Lila and Jack.

The Handmaid's Tale creator Bruce Miller on upcoming season, series' future: 'I feel like I could go on forever'
Entertainment

The Handmaid's Tale creator Bruce Miller on upcoming season, series' future: 'I feel like I could go on forever'

Miller said he’s fascinated by what unfolds in Atwood’s 2019 companion novel, The Testaments, set 15 years later. Whether it’s going to be “part of our future, that’s a bigger question,” he said. Hulu acquired rights to the book with a sequel series in mind.

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths
World

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths

A WHO Guideline Development Group of international experts said there was 'no evidence based on currently available data that the anti-viral drug does improve patient-important outcomes'

Mylan's remdesivir to cost Rs 4,800 per 100 mg vial in India, 80% cheaper than price tag in wealthy nations
Health

Mylan's remdesivir to cost Rs 4,800 per 100 mg vial in India, 80% cheaper than price tag in wealthy nations

Gilead priced remdesivir at $2,340 per patient for rich nations and agreed to send nearly all of its supply of the drug to the United States over the next three months

Coronavirus Outbreak: Gilead Sciences says supply of Remdesivir to exceed 20 lakh by end of the year
World

Coronavirus Outbreak: Gilead Sciences says supply of Remdesivir to exceed 20 lakh by end of the year

Gilead Sciences Inc expects supply of its potential COVID-19 drug Remdesivir to exceed twenty lakh courses by year-end, the company said on Monday, more than double its previous target of 10 lakh.

Hetero gets DCGI nod to launch anti-viral drug Remdesivir under brand name Covifor for COVID-19 treatment
India

Hetero gets DCGI nod to launch anti-viral drug Remdesivir under brand name Covifor for COVID-19 treatment

The drug has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease, the company said.

Treating COVID-19: As widely-available steroid dexamethasone raises hopes, a look at other potential treatments in trials already
World

Treating COVID-19: As widely-available steroid dexamethasone raises hopes, a look at other potential treatments in trials already

So far there are no approved treatments for the coronavirus infection which has claimed more than 443,000 lives globally and 9,900 in India alone

FDA warns against the usage of Remdesivir along with malaria antiviral hydroxychloroquine
science

FDA warns against the usage of Remdesivir along with malaria antiviral hydroxychloroquine

FDA said it was no longer reasonable to believe that oral formulations of HCQ maybe effective in treating the illness caused by COVID-19.

Gilead's Remdesivir prevented lung disease in macaque monkeys infected with coronavirus: Study
science

Gilead's Remdesivir prevented lung disease in macaque monkeys infected with coronavirus: Study

The antiviral drug, Remdesivir is the first drug shown to be effective against COVID-19 in human trials.

Gilead granted marketing authorisation for remdesivir for potential Covid-19 treatment in India
India

Gilead granted marketing authorisation for remdesivir for potential Covid-19 treatment in India

India has allowed adults and children who have been hospitalised with severe COVID-19 symptoms to be treated with Remdesivir

Remdesivir improved symptoms when administered to moderately ill COVID-19 patients: Gilead
science

Remdesivir improved symptoms when administered to moderately ill COVID-19 patients: Gilead

The administration of this drug will be given to patients who show signs of a sever COVID-19 infection for a period of five days as well.

Coronavirus India Update, May 14: Cases cross 78,000, Goa no longer a Green Zone, India to test 4 drugs for WHO trials
Health

Coronavirus India Update, May 14: Cases cross 78,000, Goa no longer a Green Zone, India to test 4 drugs for WHO trials

The total number of COVID-19 cases in India has reached 78,003, with the death toll surging to 2,549. The current number of active cases is 49,219.

India's Jubilant Life inks licensing agreement with Gilead to manufacture Remdesivir, a potential drug to treat COVID-19
Business

India's Jubilant Life inks licensing agreement with Gilead to manufacture Remdesivir, a potential drug to treat COVID-19

Jubilant Life Sciences Ltd on Tuesday said it has entered into a non-exclusive licensing agreement with Gilead Sciences, Inc that will grant it the right to register, manufacture and sell the latter's investigational drug, remdesivir

Jubilant Life Sciences shares jump 5% after company signs pact with Gilead COVID-19 therapy drug
Business

Jubilant Life Sciences shares jump 5% after company signs pact with Gilead COVID-19 therapy drug

Shares of Jubilant Life Sciences on Wednesday rose 5 percent after the company said it has entered into a pact with Gilead Sciences for an investigational drug, remdesivir which is a potential therapy for COVID-19

Coronavirus drugmaker Gilead Sciences's staff targeted by Iran-linked hackers: Report
News & Analysis

Coronavirus drugmaker Gilead Sciences's staff targeted by Iran-linked hackers: Report

The US FDA last week gave emergency use authorisation to Gilead's remdesivir for patients with severe COVID-19, clearing the way for broader use in more hospitals around the US.

Coronavirus India Roundup, May 6: 52,952 cases and 1,783 deaths so far, clinical trial of AYUSH medicines begins
Health

Coronavirus India Roundup, May 6: 52,952 cases and 1,783 deaths so far, clinical trial of AYUSH medicines begins

There are 35,902 active cases and 1,783 deaths have already occurred due to the pandemic. About 15,266 patients have recovered and been discharged to date.

Gilead in talks to supply Remdesivir to Europe, Asia and other developing countries to treat Coronavirus
World

Gilead in talks to supply Remdesivir to Europe, Asia and other developing countries to treat Coronavirus

Gilead was authorised to use the drug as a treatment against COVID-19 after data showed remdesivir helped patients.

Initial study of remdesivir, an antiviral drug, shows that two-thirds of severe COVID-19 patients got better
Health

Initial study of remdesivir, an antiviral drug, shows that two-thirds of severe COVID-19 patients got better

For now, Remdesivir is available for compassionate use, meaning that doctors can request the drug if a patient is in a dire situation with no alternatives.

Margaret Atwood announces sequel to her dystopian novel, The Handmaid's Tale, titled The Testament
Life

Margaret Atwood announces sequel to her dystopian novel, The Handmaid's Tale, titled The Testament

Margaret Atwood said the book is inspired by all the questions that people have about the fictional dystopian place Gilead and its inner workings